Inventor · disambiguated record
Qiaohua Kang
Also filed as: KANG QIAOHUA
1 granted patent·5 pending applications·3 citations·filing 2013–2022
20Inventor score
Top patents by PatentIndex Score
6 records- 0171US10227610B2Methods and compositions for enhancing nuclease-mediated gene disruptionSANGAMO THERAPEUTICS INC·Filed 2014·Granted Mar 12, 2019·3 cites·8 claims
- 0263US2016017366A1Crispr-based genome modification and regulationSIGMA ALDRICH CO LLC·Filed 2013·Application pending·0 cites
- 0361US2017073705A1Crispr-based genome modification and regulationSIGMA ALDRICH CO LLC·Filed 2016·Application pending·0 cites
- 0454US2019271041A1Epigenetic modification of mammalian genomes using targeted endonucleasesSIGMA ALDRICH CO LLC·Filed 2019·Application pending·0 cites
- 0547US2024409907A1Improved prime editing system efficiency with cis-acting regulatory elementsSIGMA ALDRICH CO LLC·Filed 2022·Application pending·0 cites
- 0643US2017051354A1Epigenetic modification of mammalian genomes using targeted endonucleasesSIGMA ALDRICH CO LLC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Qiaohua Kang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →